A Randomized, Double-Blind, Placebo Controlled Trial of Adalimumab for Interstitial Cystitis/Bladder Pain Syndrome
Keywords: سیستیت، التهاب مثانه; cystitis; interstitial; adalimumab; autoimmune diseases; tumor necrosis factor-alphaGRA, global response assessment; IC/BPS, interstitial cystitis/bladder pain syndrome; ICPI, Interstitial Cystitis Problem Index; ICSI, Interstitial Cystitis Symptom Index;